Lisata Therapeutics, Inc. (LSTA)

NASDAQ: LSTA · IEX Real-Time Price · USD

2.940

-0.180 (-5.77%)

At close: May 31, 2024, 4:00 PM

3.080

+0.140 (4.76%)

After-hours: May 31, 2024, 6:29 PM EDT

Lisata Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 1994
Selling, General & Admin	12.97	14.14	11.47	9.89	9.3	Upgrade
Research & Development	12.73	13.07	17.58	9.25	10.8	Upgrade
Other Operating Expenses	0	30.39	0	0	0	Upgrade
Operating Expenses	25.71	57.6	29.05	19.15	20.09	Upgrade
Operating Income	-25.71	-57.6	-29.05	-19.15	-20.09	Upgrade
Other Expense / Income	-2.54	-0.9	-0.08	-0.12	-0.73	Upgrade
Pretax Income	-23.17	-56.7	-28.97	-19.02	-19.36	Upgrade
Income Tax	-2.33	-2.48	-1.51	-10.87	0	Upgrade
Net Income	-20.84	-54.23	-27.47	-8.15	-19.36	Upgrade
Shares Outstanding (Basic)	8	5	4	1	1	Upgrade
Shares Outstanding (Diluted)	8	5	4	1	1	Upgrade
Shares Change	55.85%	40.46%	258.27%	49.54%	6.56%	Upgrade
EPS (Basic)	-2.58	-10.47	-7.45	-7.95	-28.20	Upgrade
EPS (Diluted)	-2.58	-10.47	-7.45	-7.95	-28.20	Upgrade
Free Cash Flow	-20.03	-21.46	-22.31	-8.84	-18.88	Upgrade
Free Cash Flow Per Share	-2.48	-4.14	-6.05	-8.59	-27.43	Upgrade
EBITDA	-22.98	-56.64	-28.92	-18.96	-19.3	Upgrade
Depreciation & Amortization	0.19	0.07	0.06	0.06	0.07	Upgrade
EBIT	-23.17	-56.7	-28.97	-19.02	-19.36	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).